Overgrowth Syndromes Caused by Somatic Variants in the Phosphatidylinositol 3-Kinase/AKT/Mammalian Target of Rapamycin Pathway
Authors:
- 1 July 2017
- journal article
- review article
- Published by Elsevier in The Journal of Molecular Diagnostics
- Vol. 19 (4) , 487-497
Abstract
No abstract availableKeywords
This publication has 79 references indexed in Scilit:
- Mosaic overgrowth with fibroadipose hyperplasia is caused by somatic activating mutations in PIK3CANature Genetics, 2012
- De novo germline and postzygotic mutations in AKT3, PIK3R2 and PIK3CA cause a spectrum of related megalencephaly syndromesNature Genetics, 2012
- Somatic Mosaic Activating Mutations in PIK3CA Cause CLOVES SyndromeThe American Journal of Human Genetics, 2012
- Somatic Activation of AKT3 Causes Hemispheric Developmental Brain MalformationsNeuron, 2012
- A Mosaic Activating Mutation inAKT1Associated with the Proteus SyndromeNew England Journal of Medicine, 2011
- Insulin-modulated Akt subcellular localization determines Akt isoform-specific signalingProceedings of the National Academy of Sciences, 2009
- A transforming mutation in the pleckstrin homology domain of AKT1 in cancerNature, 2007
- Rare cancer-specific mutations in PIK3CA show gain of functionProceedings of the National Academy of Sciences, 2007
- The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolismNature Reviews Genetics, 2006
- Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitiveNature Cell Biology, 2004